Nippon Shinyaku Co., Ltd. (4516.T)
JPY 3735.0
(0.89%)
JPY 3735.0
(0.89%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 25.85 Billion JPY | 13.32% |
| 2022 | 22.81 Billion JPY | -8.7% |
| 2021 | 24.98 Billion JPY | 27.87% |
| 2020 | 19.54 Billion JPY | 15.85% |
| 2019 | 16.86 Billion JPY | 3.46% |
| 2018 | 16.3 Billion JPY | 25.86% |
| 2017 | 12.95 Billion JPY | 10.25% |
| 2016 | 11.74 Billion JPY | 85.32% |
| 2015 | 6.34 Billion JPY | 7.79% |
| 2014 | 5.88 Billion JPY | 2.3% |
| 2013 | 5.75 Billion JPY | 23.74% |
| 2012 | 4.64 Billion JPY | 25.09% |
| 2011 | 3.71 Billion JPY | -6.14% |
| 2010 | 3.95 Billion JPY | -3.37% |
| 2009 | 4.09 Billion JPY | -8.96% |
| 2008 | 4.49 Billion JPY | 11.64% |
| 2007 | 4.03 Billion JPY | 39.01% |
| 2006 | 2.89 Billion JPY | 79.95% |
| 2005 | 1.61 Billion JPY | -71.43% |
| 2004 | 5.63 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 10.26 Billion JPY | 455.11% |
| 2023 Q2 | 7.42 Billion JPY | -15.12% |
| 2023 Q1 | 8.74 Billion JPY | 6239.86% |
| 2023 FY | 25.85 Billion JPY | 13.32% |
| 2023 Q4 | 1.84 Billion JPY | -76.37% |
| 2023 Q3 | 7.82 Billion JPY | 5.39% |
| 2022 Q3 | 7.45 Billion JPY | 6.88% |
| 2022 Q2 | 6.97 Billion JPY | -15.48% |
| 2022 Q1 | 8.24 Billion JPY | 246.6% |
| 2022 FY | 22.81 Billion JPY | -8.7% |
| 2022 Q4 | 138 Million JPY | -98.15% |
| 2021 FY | 24.98 Billion JPY | 27.87% |
| 2021 Q3 | 6.04 Billion JPY | 53.82% |
| 2021 Q2 | 3.93 Billion JPY | -68.15% |
| 2021 Q1 | 12.34 Billion JPY | 119.71% |
| 2021 Q4 | 2.38 Billion JPY | -60.63% |
| 2020 FY | 19.54 Billion JPY | 15.85% |
| 2020 Q1 | 5.83 Billion JPY | 17.17% |
| 2020 Q3 | 7.01 Billion JPY | 213.32% |
| 2020 Q4 | 5.61 Billion JPY | -19.89% |
| 2020 Q2 | 2.23 Billion JPY | -61.65% |
| 2019 Q2 | 3.34 Billion JPY | -32.54% |
| 2019 Q4 | 4.98 Billion JPY | 38.53% |
| 2019 FY | 16.86 Billion JPY | 3.46% |
| 2019 Q3 | 3.59 Billion JPY | 7.63% |
| 2019 Q1 | 4.95 Billion JPY | 37.38% |
| 2018 Q4 | 3.6 Billion JPY | -45.89% |
| 2018 FY | 16.3 Billion JPY | 25.86% |
| 2018 Q1 | 3.96 Billion JPY | 206.57% |
| 2018 Q2 | 2.07 Billion JPY | -47.7% |
| 2018 Q3 | 6.66 Billion JPY | 221.32% |
| 2017 Q2 | 3.03 Billion JPY | -23.24% |
| 2017 Q1 | 3.95 Billion JPY | 359.44% |
| 2017 FY | 12.95 Billion JPY | 10.25% |
| 2017 Q4 | 1.29 Billion JPY | -72.27% |
| 2017 Q3 | 4.66 Billion JPY | 53.41% |
| 2016 FY | 11.74 Billion JPY | 85.32% |
| 2016 Q1 | 3.07 Billion JPY | 132.65% |
| 2016 Q4 | -1.52 Billion JPY | -117.36% |
| 2016 Q3 | 8.79 Billion JPY | 525.77% |
| 2016 Q2 | 1.4 Billion JPY | -54.35% |
| 2015 FY | 6.34 Billion JPY | 7.79% |
| 2015 Q4 | 1.32 Billion JPY | -62.14% |
| 2015 Q3 | 3.49 Billion JPY | 282.28% |
| 2015 Q2 | 914 Million JPY | 50.08% |
| 2015 Q1 | 609 Million JPY | -60.51% |
| 2014 FY | 5.88 Billion JPY | 2.3% |
| 2014 Q1 | 692 Million JPY | -62.61% |
| 2014 Q2 | 748 Million JPY | 8.09% |
| 2014 Q3 | 2.9 Billion JPY | 287.7% |
| 2014 Q4 | 1.54 Billion JPY | -46.83% |
| 2013 Q3 | 1.75 Billion JPY | 80.45% |
| 2013 FY | 5.75 Billion JPY | 23.74% |
| 2013 Q1 | 1.17 Billion JPY | 7.61% |
| 2013 Q2 | 972 Million JPY | -17.14% |
| 2013 Q4 | 1.85 Billion JPY | 5.53% |
| 2012 Q4 | 1.09 Billion JPY | -25.55% |
| 2012 Q1 | 1.28 Billion JPY | 102.21% |
| 2012 Q3 | 1.46 Billion JPY | 80.52% |
| 2012 Q2 | 811 Million JPY | -36.74% |
| 2012 FY | 4.64 Billion JPY | 25.09% |
| 2011 Q2 | 701 Million JPY | -46.53% |
| 2011 Q3 | 1.06 Billion JPY | 52.5% |
| 2011 Q4 | 634 Million JPY | -40.69% |
| 2011 FY | 3.71 Billion JPY | -6.14% |
| 2011 Q1 | 1.31 Billion JPY | 42.5% |
| 2010 Q3 | 1.58 Billion JPY | 1355.96% |
| 2010 Q2 | 109 Million JPY | -91.87% |
| 2010 Q1 | 1.34 Billion JPY | 696.0% |
| 2010 Q4 | 920 Million JPY | -42.03% |
| 2010 FY | 3.95 Billion JPY | -3.37% |
| 2009 Q4 | -225 Million JPY | -109.81% |
| 2009 FY | 4.09 Billion JPY | -8.96% |
| 2009 Q3 | 2.29 Billion JPY | 314.83% |
| 2009 Q2 | 553 Million JPY | -62.48% |
| 2009 Q1 | 1.47 Billion JPY | 131.03% |
| 2008 Q2 | 129 Million JPY | 0.0% |
| 2008 FY | 4.49 Billion JPY | 11.64% |
| 2008 Q3 | 808 Million JPY | 526.36% |
| 2008 Q4 | 638 Million JPY | -21.04% |
| 2007 FY | 4.03 Billion JPY | 39.01% |
| 2006 FY | 2.89 Billion JPY | 79.95% |
| 2005 FY | 1.61 Billion JPY | -71.43% |
| 2004 FY | 5.63 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -706.583% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 82.056% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 108.207% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 84.046% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -23625.438% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | -222.131% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 39.041% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -3608.895% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | -85.06% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | -468.529% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -1777.342% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 14461.667% |
| Tsumura & Co. | 16.7 Billion JPY | -54.732% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | -131.64% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | -527.604% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | -59.84% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -652.576% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | -234.37% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | -385.738% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 628.218% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -684.552% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 1417.036% |
| MedRx Co., Ltd | -932 Million JPY | 2873.712% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -584.933% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 2424.73% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 1180.808% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | -242.624% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | -88.762% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 4487.393% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | -25.144% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -777.395% |